Hualan Vaccine (301207.SZ) announced that as of August 31, 2024, the company had traded through centralized competitive bidding...
According to the Zhitong Finance APP, Hualan Vaccine (301207.SZ) announced that as of August 31, 2024, the company has repurchased a cumulative total of 5.6008 million shares through centralized competitive bidding, accounting for 0.93% of the company's current total share capital, with a total transaction amount of 99.1311 million yuan (excluding transaction costs).